Thomas D.  Michl

Dr. Thomas D. Michl

Future Industries Institute, University of South Australia, Mawson Lakes Blvd, Mawson Lakes, SA 5095, Australia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2014 in ACS Macro Letters
Verified
Journal Article
Closed access
KLKatherine E. S. Locock
Katherine E. S. Locock
Thomas D.  MichlThomas D. Michl
Thomas D. Michl
NSNatalie Emilia Stevens
Natalie Emilia Stevens
JHJohn Hayball
John Hayball
Krasimir VasilevKrasimir Vasilev
Krasimir Vasilev
MHMatthias Haeussler
Matthias Haeussler

16 June 2014 in Polymer Chemistry
Verified
Journal Article
Closed access
PDF file
Thomas D.  MichlThomas D. Michl
Thomas D. Michl
KLKatherine E. S. Locock
Katherine E. S. Locock
NSNatalie Emilia Stevens
Natalie Emilia Stevens
JHJohn Hayball
John Hayball
Krasimir VasilevKrasimir Vasilev
Krasimir Vasilev
HGHans Griesser
Hans Griesser
Antimicrobial polymers as mimics of natural antimicrobial peptides are emerging as an alternative to classic antibiotics due to their potency, selectivity and lower susceptibility to resistance. The key chemical aspects necessary to confer high activity and selectivity to the polymer chain composition are largely known. However, little attention has been paid to how end-groups affect the overall biological activity. Here we report the use of RAFT polymerization to obtain eight well-defined cationic methacrylate polymers which bear either amine (PA1–4) or guanidine (PG1–4) pendant groups, while systematically varying the R- and Z-RAFT end-groups. These polymers were assessed in haemotoxicity assays as well as antimicrobial testing against clinically relevant pathogens; such as a vigorously biofilm forming strain of Staphylococcus epidermidis (S. epidermidis) and a vancomycin and methicillin resistant strain of Staphylococcus aureus (VISA) as well as the opportunistic fungus Candida albicans (C. albicans). The R-group was found to dominate the measured toxicity of polymers. Replacement of the anionic cyanovaleric acid R-group (PA1) with the neutral isobutyronitrile (PA3) led to over a 20 fold increase in the haemolytic activity of the polymers. The Z-group, however, was found to have more influence on the antimicrobial activity of the polymers against both VISA and C. albicans, whereby polymers with a long, lipophilic dodecylsulfanyl Z-group (PA1) were found to be more potent than those with either an ethylsulfanyl or no ZCS2-group. These results indicate that chemical control over the end-groups is a key element for achieving the desired high biological activity and selectivity, particularly when low molecular weights are required for maximum antibacterial activity.

19 March 2015 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
Thomas D.  MichlThomas D. Michl
Thomas D. Michl
BCBryan Coad
Bryan Coad
Michael Robert DoranMichael Robert Doran
Michael Robert Doran
MOMichael Osiecki
Michael Osiecki
MKMorteza Hasanzadeh Kafshgari
Morteza Hasanzadeh Kafshgari
HGHans Griesser
Hans Griesser
We report a stable plasma polymer coating which releases nitric oxide, inhibiting bacterial growth without cytotoxic side effects.

16 August 2011 in Chemistry – A European Journal
Verified
Journal Article
Closed access
PDF file
ASAlexander Schaetz
Alexander Schaetz
MZMartin Zeltner
Martin Zeltner
Thomas D.  MichlThomas D. Michl
Thomas D. Michl
MRMichael Rossier
Michael Rossier
RFRoland Fuhrer
Roland Fuhrer
WSWendelin J. Stark
Wendelin J. Stark

20 August 2014 in Pure and Applied Chemistry
Verified
Journal Article
Closed access
KLKatherine E.S. Locock
Katherine E.S. Locock
Thomas D.  MichlThomas D. Michl
Thomas D. Michl
HGHans Griesser
Hans Griesser
MHMatthias Haeussler
Matthias Haeussler
LMLaurence Meagher
Laurence Meagher
Host-defense antimicrobial peptides (AMPs) are a promising lead in the search for novel antibiotics. Many of these peptides exhibit broad-spectrum antibacterial ability, low toxicity toward human cells, and little susceptibility to induction of bacterial resistance. Our research focuses on the development of synthetic polymers that are able to mimic the amphiphilic and cation-rich characteristics of AMPs. This derives bioactive polymers that retain the activity profile of AMPs while utilizing a construct that is less expensive and easier to produce and manipulate chemically. This review details structure–activity relationships (SARs) of a new class of arginine-rich, synthetic AMP mimicking polymers (SAMPs), the guanylated polymethacrylates. These are contrasted with those of amine-based polymers that are mimics of lysine-rich AMPs. The ideal composition for candidates for practical applications was identified as those containing guanidines as a cation source, having a low molecular weight and a low level of lipophilicity. This gave polymers with high potency against Gram-positive strains of bacteria (e.g., Staphylococcus epidermidis MIC = 10 μg/mL) and low toxicity towards human red blood cells (<4% hemolysis at given MIC). This work emphasizes the need to rationalize observed biological activities based not purely on the global lipophilic and cationic character of polymers but rather to consider the profound effect that specific pendant functional groups may have on the potency, selectivity, and mechanisms behind the action of antimicrobial polymers.

17 November 2014 in Plasma Processes and Polymers
Verified
Journal Article
Closed access
PDF file
Thomas D.  MichlThomas D. Michl
Thomas D. Michl
BCBryan Coad
Bryan Coad
AHAmanda Hüsler
Amanda Hüsler
Krasimir VasilevKrasimir Vasilev
Krasimir Vasilev
HGHans Griesser
Hans Griesser